CLINICAL_TRIALS
trial_result
· 2026-01-28
Clinical Trial Update: Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis [Phase 2]
Summary
A Phase 2 study evaluating the efficacy, safety and tolerability of DFV890 in knee osteoarthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Symptomatic Knee Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2026-01-28